相关实验视频
Updated: Sep 15, 2025

04:09
Minimal Invasive Resection of Large Retrosternal Thyroid Goiter
Published on: September 20, 2024
409
甲状腺毒性症中心血管并发症的风险:甲状腺切除术与非手术治疗相比
Zhixing Song1, Niranjna Swaminathan1, Julia Kasmirski1
1Department of Surgery, University of Alabama at Birmingham, Birmingham, Alabama.
The Journal of surgical research
|July 17, 2025
概括
与医疗或放射性 (RAI) 治疗相比,甲状腺切除术显著降低了甲状腺毒性患者的心血管风险和死亡率. 这种明确的方法为治疗甲状腺功能增强症提供了更好的长期心血管结果.
科学领域:
- 内分泌学 在内分泌学.
- 心血管医学 心血管医学
- 手术瘤学手术瘤学
背景情况:
- 甲状腺毒性病是一种超代谢状态,需要通过抗甲状腺药物,放射性 (RAI) 或甲状腺切除术进行治疗.
- 甲状腺毒素治疗的长期心血管后果尚未完全理解.
- 这项研究调查了手术与非手术干预对胆固醇毒性病的新发性心血管并发症的比较影响.
研究的目的:
- 评估甲状腺切除术与甲状腺毒素症患者心血管结果之间的关联.
- 为了比较手术和非手术治疗方式之间的心血管事件和死亡风险.
- 评估特定心血管并发症的发生率,包括脑梗塞,心房动/动和心力衰竭,在不同类毒素治疗后.
主要方法:
- 用TriNetX数据库对2005-2024年电子病历进行了回顾性分析.
- 鉴定和选择诊断为甲状腺毒素症的患者队列.
- 倾向性得分匹配 (1:1) 以平衡手术和非手术组,然后进行卡普兰-梅尔分析以确定危险比率 (HR) 和95%置信区间 (CI).
主要成果:
- 与药物治疗相比,甲状腺切除术与复合心血管结局 (HR 0.82) 和全因死亡率 (HR 0.60) 的风险降低有关.
- 甲状腺切除术显示,与医疗治疗相比,发生脑梗塞 (HR 0.78),心房动/动 (HR 0.57),心力衰竭 (HR 0.71) 的风险较低.
- 与RAI相比,甲状腺切除显示了复合心血管结局的风险较低 (HR 0.81),但死亡率没有显著差异;然而,它增加了缺甲状腺症和声带的风险.
结论:
- 甲状腺切除术与与医疗和放射性 (RAI) 治疗相比显著降低心血管风险有关.
- 甲状腺切除术的最终手术方法为甲状腺毒性病患者提供了优越的长期心血管保护.
- 虽然甲状腺切除术具有较高的特定并发症风险,如甲状腺功能低下症和声带,但其整体心血管益处是显著的.
相关概念视频
Cardiomyopathy VII: Pre and Post Operative Nursing Management
29
Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
29
Mitral Stenosis III: Medical Management
27
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
27
Pericarditis III: Medical Management
26
The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
26
Atherosclerosis III: Management
40
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
40
Cardiomyopathy V: Interprofessional Care
37
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
37
Myocarditis III: Medical Management
17
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
17

